Financials

Discussions Technicals Seasonals

6949 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to PELL BIO-MED TECHNOLOGY CO LTD operating, investing, and financing activities

6949 free cash flow for Q4 24 is -218.19 M TWD. For 2024, 6949 free cash flow was -523.93 M TWD and operating cash flow was -260.14 M TWD.

Q1 '23

Q2 '23

Q3 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: TWD

Q1 '23

Q2 '23

Q3 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—